URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Louis Constine

Concepts (482)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Hodgkin Disease
38
1982
155
7.120
Why?
Neoplasms, Second Primary
17
2000
125
4.250
Why?
Radiotherapy
31
1981
198
4.160
Why?
Radiation Injuries
21
1988
131
3.960
Why?
Neoplasms
21
1981
739
2.720
Why?
Survivors
17
1993
118
2.400
Why?
Sarcoma
5
1992
63
2.310
Why?
Antineoplastic Combined Chemotherapy Protocols
16
1985
429
2.170
Why?
Cardiovascular Diseases
11
2003
277
1.840
Why?
Neoplasms, Radiation-Induced
11
1995
80
1.680
Why?
Stem Cell Transplantation
3
1999
110
1.430
Why?
Neoplasm Recurrence, Local
8
1995
288
1.420
Why?
Child
52
1973
4155
1.420
Why?
Soft Tissue Neoplasms
3
1992
46
1.390
Why?
Radiotherapy Dosage
22
1981
203
1.370
Why?
Lung Neoplasms
6
1985
439
1.320
Why?
Humans
116
1973
36274
1.300
Why?
Aging
5
2006
707
1.220
Why?
Adolescent
45
1981
4766
1.200
Why?
Combined Modality Therapy
24
1984
486
1.150
Why?
Adult
51
1981
11351
1.120
Why?
Breast Neoplasms
8
2008
673
1.010
Why?
Bone Marrow Transplantation
8
1984
197
0.980
Why?
Hematopoietic Stem Cell Transplantation
4
1998
131
0.980
Why?
Whole-Body Irradiation
7
1984
83
0.960
Why?
Young Adult
16
2009
1059
0.930
Why?
Child, Preschool
31
1973
2660
0.920
Why?
Heart
5
1995
236
0.920
Why?
Radiation Oncology
5
2008
18
0.880
Why?
Risk Factors
20
1991
2345
0.850
Why?
Female
69
1973
19838
0.840
Why?
Lymphoma, Large B-Cell, Diffuse
2
2009
78
0.820
Why?
Antineoplastic Agents
11
1985
619
0.810
Why?
Male
57
1973
19675
0.800
Why?
Brain Neoplasms
5
1987
281
0.780
Why?
Central Nervous System Neoplasms
2
1999
22
0.770
Why?
Fractures, Spontaneous
1
2010
15
0.750
Why?
Cell Aging
2
2010
57
0.730
Why?
Leg
1
2010
98
0.720
Why?
Graft vs Host Disease
3
1999
90
0.710
Why?
Radiosurgery
1
2011
74
0.710
Why?
Bone Density
1
2010
111
0.700
Why?
Incidence
10
1995
685
0.700
Why?
Cell Transformation, Neoplastic
2
2010
137
0.700
Why?
Middle Aged
30
1987
9837
0.670
Why?
Radiation Tolerance
9
1981
89
0.660
Why?
Anthracyclines
5
2007
17
0.650
Why?
DNA Repair
1
2010
172
0.630
Why?
Heart Diseases
4
1995
142
0.620
Why?
Neoplasm Staging
12
1985
338
0.600
Why?
Dose-Response Relationship, Radiation
14
1984
219
0.590
Why?
Practice Guidelines as Topic
4
2008
302
0.580
Why?
Skin Diseases
1
2008
120
0.580
Why?
Tomography, X-Ray Computed
8
1988
759
0.580
Why?
Aged
19
1987
7269
0.580
Why?
Follow-Up Studies
16
1984
1855
0.580
Why?
Leukemia, Myeloid, Acute
1
2008
177
0.560
Why?
Time Factors
15
1982
3182
0.550
Why?
Stereotaxic Techniques
1
2006
33
0.550
Why?
Radiology
3
1992
29
0.550
Why?
Liver Neoplasms
2
2006
151
0.540
Why?
Disease
1
2006
36
0.530
Why?
Dose Fractionation
4
2006
60
0.530
Why?
Risk Assessment
8
2004
884
0.530
Why?
Survival Rate
13
1990
618
0.520
Why?
Survival Analysis
10
1993
606
0.520
Why?
Thyroid Neoplasms
5
1995
65
0.520
Why?
Infant
13
1981
2278
0.520
Why?
Transplantation, Autologous
7
1984
144
0.510
Why?
Diagnostic Imaging
5
1995
87
0.510
Why?
Glioma
2
1987
102
0.500
Why?
Amifostine
4
1985
27
0.480
Why?
Hypothyroidism
6
1982
43
0.470
Why?
Bone Marrow
6
1984
287
0.470
Why?
Treatment Outcome
12
1996
2615
0.470
Why?
Antibiotics, Antineoplastic
3
1993
50
0.460
Why?
Optic Nerve Neoplasms
1
2003
2
0.450
Why?
Neurofibromatosis 1
1
2003
7
0.450
Why?
Endocrine System Diseases
3
1997
13
0.430
Why?
Salvage Therapy
3
2009
59
0.420
Why?
Recurrence
6
1997
691
0.410
Why?
Thyroid Gland
3
1993
54
0.400
Why?
Medical Oncology
2
1992
48
0.390
Why?
Population Surveillance
4
2001
136
0.380
Why?
Radiation-Protective Agents
3
1986
41
0.380
Why?
Prognosis
9
1996
1083
0.360
Why?
Antibodies, Monoclonal, Murine-Derived
2
2009
114
0.360
Why?
Cyclophosphamide
6
1998
174
0.350
Why?
Models, Statistical
3
2010
226
0.350
Why?
Thymus Gland
2
2010
144
0.350
Why?
Rhabdoid Tumor
1
1999
5
0.340
Why?
Ventriculoperitoneal Shunt
1
1999
12
0.340
Why?
Peritoneal Neoplasms
1
1999
26
0.340
Why?
Pituitary Neoplasms
2
1989
66
0.320
Why?
Hypothalamo-Hypophyseal System
2
1995
54
0.320
Why?
Neoadjuvant Therapy
2
2007
32
0.310
Why?
Lung Diseases
3
2006
228
0.300
Why?
Age Distribution
4
2010
221
0.300
Why?
Sex Factors
7
1975
597
0.300
Why?
Retrospective Studies
8
1985
2267
0.300
Why?
Age Factors
9
1973
1128
0.290
Why?
Organothiophosphorus Compounds
2
1986
8
0.290
Why?
Severity of Illness Index
3
1995
922
0.280
Why?
Models, Biological
4
1988
1008
0.280
Why?
Methotrexate
3
1990
73
0.280
Why?
Transplantation, Homologous
4
1999
276
0.270
Why?
Cell Proliferation
2
2010
515
0.270
Why?
Rhabdomyosarcoma
1
1995
12
0.260
Why?
Cranial Irradiation
3
1990
14
0.260
Why?
Magnetic Resonance Imaging
5
1988
991
0.260
Why?
Medulloblastoma
3
1987
20
0.260
Why?
Thyroid Diseases
1
1995
20
0.260
Why?
Cerebellar Neoplasms
3
1987
23
0.250
Why?
Siblings
2
2010
36
0.250
Why?
Fibroblast Growth Factor 2
3
1998
83
0.250
Why?
Lymphoma, Non-Hodgkin
2
1997
113
0.250
Why?
Lymphoma
2
1998
162
0.240
Why?
Clinical Trials as Topic
6
1985
671
0.240
Why?
Doxorubicin
4
1990
107
0.240
Why?
Disease-Free Survival
6
1998
198
0.240
Why?
Head and Neck Neoplasms
1
1995
83
0.240
Why?
Radiation Dosage
6
1993
125
0.240
Why?
Radiotherapy, Adjuvant
3
1998
73
0.230
Why?
Bone Development
2
1987
82
0.220
Why?
Morbidity
2
2009
75
0.220
Why?
Pituitary Gland
1
1993
62
0.220
Why?
Hypothalamus
1
1993
89
0.210
Why?
Guideline Adherence
2
2010
83
0.210
Why?
Gonadal Disorders
1
2012
1
0.210
Why?
Reproductive Health
1
2012
1
0.210
Why?
Gastrointestinal Neoplasms
1
2012
20
0.210
Why?
Hyperprolactinemia
2
1987
7
0.210
Why?
Vincristine
3
1990
62
0.210
Why?
Brain
2
1988
1214
0.200
Why?
Echocardiography
2
1993
228
0.200
Why?
Carcinoma, Ductal, Breast
2
2008
40
0.200
Why?
Quality Assurance, Health Care
2
2009
123
0.200
Why?
Histiocytoma, Malignant Fibrous
1
2011
5
0.190
Why?
Colony-Forming Units Assay
1
1991
39
0.190
Why?
Aged, 80 and over
5
1992
2529
0.190
Why?
United States
7
1992
2688
0.190
Why?
Sarcoma, Synovial
1
2011
7
0.190
Why?
Leiomyosarcoma
1
2011
18
0.190
Why?
Databases, Factual
2
1999
156
0.190
Why?
Remission Induction
2
1997
161
0.190
Why?
Adiposity
1
2010
11
0.190
Why?
Growth Plate
2
2001
142
0.190
Why?
Weight-Bearing
1
2010
43
0.190
Why?
Cytoprotection
1
2010
37
0.190
Why?
Carcinoma, Non-Small-Cell Lung
1
2011
72
0.180
Why?
Prednisone
2
1998
165
0.180
Why?
Predictive Value of Tests
5
1999
606
0.180
Why?
Meta-Analysis as Topic
1
2010
36
0.180
Why?
Information Dissemination
1
2010
24
0.180
Why?
Clinical Protocols
1
2010
106
0.180
Why?
Antibodies, Monoclonal
3
1985
711
0.180
Why?
Chronic Disease
2
1991
522
0.180
Why?
Interleukin-1
1
1991
218
0.170
Why?
Osteonecrosis
1
2010
24
0.170
Why?
Testicular Neoplasms
1
2010
55
0.170
Why?
Chemotherapy, Adjuvant
2
1996
88
0.170
Why?
Brain Injuries
1
2011
106
0.170
Why?
Infertility
2
2006
22
0.170
Why?
Thyroid Hormones
2
1984
34
0.170
Why?
Intelligence
1
1990
109
0.170
Why?
Craniopharyngioma
1
1989
5
0.170
Why?
Fractures, Bone
1
2010
95
0.170
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1990
82
0.170
Why?
Health Status
1
2012
283
0.170
Why?
Homeostasis
1
2010
177
0.160
Why?
Splenectomy
1
2008
35
0.160
Why?
Abdominal Neoplasms
1
2008
17
0.160
Why?
DNA Damage
1
2010
170
0.160
Why?
Leukemia
2
1999
158
0.160
Why?
Carmustine
4
1987
37
0.160
Why?
Biopsy, Fine-Needle
1
2008
21
0.160
Why?
Analysis of Variance
2
1999
736
0.160
Why?
Carcinoid Tumor
1
2008
26
0.160
Why?
Neoplasm Metastasis
2
1985
228
0.160
Why?
Carcinoma in Situ
1
2008
41
0.160
Why?
Adenoma
1
2008
54
0.160
Why?
Glioblastoma
3
1988
63
0.160
Why?
Quality of Life
3
2005
502
0.160
Why?
Statistics as Topic
1
2008
185
0.160
Why?
Etoposide
5
1998
83
0.150
Why?
Regeneration
2
1984
61
0.150
Why?
Biomedical Research
1
2009
139
0.150
Why?
Razoxane
1
2007
7
0.150
Why?
Pediatrics
1
1992
391
0.150
Why?
Patient Care Planning
1
2007
71
0.150
Why?
SEER Program
3
2010
53
0.140
Why?
Chelating Agents
1
2007
67
0.140
Why?
Aging, Premature
1
2006
7
0.140
Why?
Delivery of Health Care
1
2008
146
0.140
Why?
Tumor Burden
1
2006
22
0.140
Why?
Radiotherapy, Computer-Assisted
1
2006
15
0.140
Why?
Leukemia, Myeloid
1
2007
119
0.140
Why?
Cohort Studies
4
2007
969
0.140
Why?
Oxidative Stress
1
2010
346
0.140
Why?
Odds Ratio
3
2010
315
0.140
Why?
Cartilage
1
1987
158
0.130
Why?
Transplantation Conditioning
2
1999
33
0.130
Why?
Foundations
1
2005
12
0.130
Why?
Apoptosis
2
2002
823
0.130
Why?
Myelodysplastic Syndromes
1
2007
131
0.130
Why?
Radiotherapy Planning, Computer-Assisted
3
2008
48
0.130
Why?
Adenocarcinoma
1
2008
439
0.120
Why?
Skin
1
1987
377
0.120
Why?
Nervous System Diseases
1
2006
147
0.120
Why?
Thyrotropin
3
1982
32
0.120
Why?
Puberty, Precocious
2
1995
4
0.120
Why?
Cardiomyopathies
2
1993
82
0.120
Why?
Animals
15
1981
16093
0.120
Why?
Hematopoietic Stem Cells
4
1984
197
0.120
Why?
Ventricular Function, Left
2
1990
95
0.120
Why?
Coronary Disease
2
1995
258
0.110
Why?
Optic Chiasm
1
2003
7
0.110
Why?
Cognition Disorders
1
2007
286
0.110
Why?
Prostatic Neoplasms
2
1985
555
0.110
Why?
Mediastinum
1
2003
20
0.110
Why?
Infant, Newborn
5
1981
1844
0.110
Why?
Stomatitis
2
1999
16
0.110
Why?
Fibrosis
2
1995
60
0.110
Why?
Visual Pathways
1
2003
78
0.110
Why?
Pentoxifylline
1
2002
26
0.100
Why?
Mental Disorders
1
2006
347
0.100
Why?
Myocardial Infarction
3
1996
660
0.100
Why?
Platinum Compounds
2
2010
7
0.100
Why?
Rabbits
4
1984
697
0.100
Why?
European Continental Ancestry Group
2
1996
234
0.100
Why?
Infertility, Male
2
2010
34
0.100
Why?
Growth
1
1981
39
0.100
Why?
Astrocytoma
2
1988
30
0.090
Why?
Myocardium
2
1995
294
0.090
Why?
Transforming Growth Factor beta
2
1998
412
0.090
Why?
Dose-Response Relationship, Drug
4
1987
1117
0.090
Why?
Hyperthyroidism
2
1982
24
0.090
Why?
Exercise Test
2
1993
101
0.090
Why?
Coronary Artery Disease
2
2010
96
0.090
Why?
Nifedipine
1
1999
31
0.090
Why?
Parenteral Nutrition
1
1999
23
0.090
Why?
Methylprednisolone
1
1999
43
0.090
Why?
Cytarabine
3
1998
89
0.090
Why?
Ring Chromosomes
1
1999
5
0.090
Why?
Chromosomes, Human, Pair 22
1
1999
12
0.090
Why?
Mouth Mucosa
1
1999
43
0.090
Why?
Cyclosporine
1
1999
64
0.080
Why?
Calcium Signaling
1
2002
190
0.080
Why?
Models, Animal
2
2010
138
0.080
Why?
Calcium Channel Blockers
1
1999
67
0.080
Why?
Case-Control Studies
2
2010
617
0.080
Why?
Chondrocytes
1
2002
291
0.080
Why?
Pituitary Hormones
2
1995
13
0.080
Why?
Research
2
2010
178
0.080
Why?
Genetic Predisposition to Disease
2
2010
331
0.080
Why?
Cause of Death
3
1990
162
0.080
Why?
Exercise Tolerance
1
1997
11
0.080
Why?
Immunosuppressive Agents
1
1999
200
0.080
Why?
Diastole
1
1997
26
0.080
Why?
Bone Neoplasms
2
1985
207
0.080
Why?
Radiation Pneumonitis
2
2007
44
0.080
Why?
Risk
2
2007
368
0.080
Why?
Neovascularization, Physiologic
1
1998
124
0.070
Why?
Fatigue
2
2007
124
0.070
Why?
Bleomycin
3
1990
47
0.070
Why?
Stroke Volume
1
1997
154
0.070
Why?
Gene Expression Regulation
1
2002
888
0.070
Why?
Evidence-Based Medicine
2
2004
202
0.070
Why?
Reproducibility of Results
2
2008
877
0.070
Why?
Ploidies
1
1995
18
0.070
Why?
Multicenter Studies as Topic
1
1996
129
0.070
Why?
Genes, myc
1
1995
29
0.070
Why?
Drug Resistance, Multiple
1
1995
30
0.070
Why?
Pituitary Hormones, Anterior
1
1995
5
0.070
Why?
Pericardium
1
1995
16
0.060
Why?
Genes, Tumor Suppressor
1
1995
49
0.060
Why?
Follicle Stimulating Hormone
1
1995
52
0.060
Why?
Bone and Bones
1
1998
355
0.060
Why?
African Continental Ancestry Group
1
1996
125
0.060
Why?
Growth Hormone
1
1995
103
0.060
Why?
Luteinizing Hormone
1
1995
58
0.060
Why?
Adrenocorticotropic Hormone
1
1995
75
0.060
Why?
Injury Severity Score
1
1995
73
0.060
Why?
Neuroblastoma
2
1985
93
0.060
Why?
Proportional Hazards Models
2
1996
450
0.060
Why?
Cell Cycle
1
1995
254
0.060
Why?
Mice
7
1981
6111
0.060
Why?
Prospective Studies
3
1993
1689
0.060
Why?
Randomized Controlled Trials as Topic
1
1996
411
0.060
Why?
Gonads
1
1993
6
0.060
Why?
Supratentorial Neoplasms
1
1993
8
0.060
Why?
Hypogonadism
1
1993
14
0.050
Why?
Adrenal Glands
1
1993
51
0.050
Why?
Positron-Emission Tomography and Computed Tomography
1
2012
1
0.050
Why?
Multivariate Analysis
2
1990
541
0.050
Why?
Semen Preservation
1
2012
2
0.050
Why?
Puberty, Delayed
1
2012
3
0.050
Why?
Procarbazine
1
2012
12
0.050
Why?
Laparotomy
1
1992
35
0.050
Why?
Sexual Dysfunction, Physiological
1
2012
12
0.050
Why?
Cryopreservation
1
2012
26
0.050
Why?
Canada
1
2012
75
0.050
Why?
Natriuretic Peptide, Brain
1
2012
11
0.050
Why?
Radiotherapy, Intensity-Modulated
1
2012
6
0.050
Why?
Acute Disease
2
2000
586
0.050
Why?
Confounding Factors (Epidemiology)
1
2012
61
0.050
Why?
Radiotherapy, Conformal
1
2012
19
0.050
Why?
Confidence Intervals
1
2012
165
0.050
Why?
Heart Block
1
2012
57
0.050
Why?
Age of Onset
1
2012
126
0.050
Why?
Parathyroid Hormone-Related Protein
2
2001
105
0.050
Why?
Matched-Pair Analysis
1
2011
17
0.050
Why?
Cholesterol
1
2012
137
0.050
Why?
Kaplan-Meier Estimate
1
2012
222
0.050
Why?
Outcome and Process Assessment (Health Care)
1
1992
85
0.050
Why?
Tumor Stem Cell Assay
1
1991
24
0.050
Why?
Testosterone
1
2012
158
0.050
Why?
Carcinoma, Lobular
1
2011
24
0.050
Why?
Pancytopenia
1
2010
13
0.050
Why?
Maximum Tolerated Dose
1
2010
17
0.050
Why?
C-Reactive Protein
1
2012
122
0.050
Why?
Melphalan
1
2010
28
0.050
Why?
Mucositis
1
2010
13
0.050
Why?
Lymph Nodes
1
1992
206
0.050
Why?
Peripheral Blood Stem Cell Transplantation
1
2010
20
0.050
Why?
Granulocytes
1
1991
80
0.050
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2011
40
0.050
Why?
Paresthesia
1
2010
18
0.050
Why?
Polymorphism, Genetic
1
2012
201
0.050
Why?
Colorectal Neoplasms
1
2012
137
0.050
Why?
Genome-Wide Association Study
1
2010
21
0.050
Why?
Renal Insufficiency
1
2010
21
0.050
Why?
Radioactive Fallout
1
2010
2
0.050
Why?
Pericarditis
1
2010
11
0.050
Why?
Coronary Circulation
1
1990
90
0.050
Why?
Injections, Spinal
1
1990
26
0.040
Why?
Peptide Fragments
1
2012
282
0.040
Why?
Employment
1
2010
64
0.040
Why?
Hypertrophy
1
2010
66
0.040
Why?
Societies, Medical
1
2011
138
0.040
Why?
Stroke
1
2012
134
0.040
Why?
Prednisolone
1
2009
24
0.040
Why?
Arrhythmias, Cardiac
1
2012
246
0.040
Why?
Organ Specificity
1
2010
162
0.040
Why?
Adipose Tissue
1
2010
137
0.040
Why?
Postoperative Complications
2
1992
733
0.040
Why?
Forecasting
1
2010
177
0.040
Why?
Atrial Fibrillation
1
2010
110
0.040
Why?
Pulmonary Fibrosis
1
2010
140
0.040
Why?
Body Mass Index
1
2010
218
0.040
Why?
Translational Medical Research
1
2009
38
0.040
Why?
Disease Progression
1
2011
521
0.040
Why?
Biological Markers
1
2012
560
0.040
Why?
Radiobiology
1
2008
10
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2001
542
0.040
Why?
Occupational Exposure
1
2010
114
0.040
Why?
Proteins
2
2001
468
0.040
Why?
Rats
2
1981
4289
0.040
Why?
Radiation Injuries, Experimental
1
1988
90
0.040
Why?
Cognition
1
2010
227
0.040
Why?
Spinal Cord
1
1988
165
0.040
Why?
Leukemia, Radiation-Induced
1
2007
11
0.040
Why?
Palliative Care
2
1985
159
0.040
Why?
Topoisomerase II Inhibitors
1
2007
8
0.040
Why?
Antineoplastic Agents, Alkylating
1
2007
42
0.040
Why?
Time
1
2007
46
0.040
Why?
Meningeal Neoplasms
1
1987
50
0.040
Why?
Meningioma
1
1987
53
0.040
Why?
Osteosarcoma
1
2007
71
0.040
Why?
Reference Values
1
2007
439
0.030
Why?
Italy
1
2005
22
0.030
Why?
Radiation-Sensitizing Agents
2
1982
75
0.030
Why?
Mice, Inbred C57BL
1
1991
1675
0.030
Why?
Sarcoma, Ewing
1
1985
10
0.030
Why?
Wilms Tumor
1
1985
11
0.030
Why?
Antigens, Neoplasm
1
1986
106
0.030
Why?
Nursing Care
1
2004
15
0.030
Why?
Congenital Abnormalities
1
1985
36
0.030
Why?
Skin Physiological Phenomena
2
1973
19
0.030
Why?
Enzyme Inhibitors
1
2007
422
0.030
Why?
RNA, Messenger
2
2001
1863
0.030
Why?
Thyroxine
1
1984
46
0.030
Why?
Joints
2
1973
58
0.030
Why?
Kidney Neoplasms
1
1985
103
0.030
Why?
Cell Separation
1
1984
231
0.030
Why?
Longitudinal Studies
1
2004
395
0.030
Why?
Nitroimidazoles
1
1982
11
0.030
Why?
Neck
1
1982
34
0.030
Why?
Genes, bcl-2
1
2002
23
0.030
Why?
Drug Evaluation, Preclinical
1
2002
76
0.020
Why?
Research Design
1
2004
336
0.020
Why?
Chick Embryo
1
2002
190
0.020
Why?
Receptors, Parathyroid Hormone
1
2001
13
0.020
Why?
Receptor, Parathyroid Hormone, Type 1
1
2001
23
0.020
Why?
Cytosol
1
2002
192
0.020
Why?
Proto-Oncogene Proteins c-bcl-2
1
2002
116
0.020
Why?
Sodium Pertechnetate Tc 99m
1
2000
10
0.020
Why?
Chickens
1
2001
299
0.020
Why?
Radiopharmaceuticals
1
2000
48
0.020
Why?
Myeloablative Agonists
1
2000
6
0.020
Why?
Nuclear Family
1
2000
13
0.020
Why?
Drug Toxicity
1
2000
16
0.020
Why?
Drug Evaluation
1
2000
101
0.020
Why?
Blood Grouping and Crossmatching
1
2000
32
0.020
Why?
Protein Biosynthesis
1
2002
264
0.020
Why?
DNA Primers
1
2001
403
0.020
Why?
Anemia, Aplastic
1
1999
25
0.020
Why?
Wiskott-Aldrich Syndrome
1
1999
9
0.020
Why?
Life Tables
1
1999
39
0.020
Why?
Gestational Age
1
1981
339
0.020
Why?
Fetus
1
1981
253
0.020
Why?
Graft Survival
1
2000
148
0.020
Why?
Diarrhea
1
1999
66
0.020
Why?
Hematologic Neoplasms
1
1999
35
0.020
Why?
Cell Division
1
2002
762
0.020
Why?
Lymphotoxin-alpha
1
1998
11
0.020
Why?
Laser-Doppler Flowmetry
1
1998
20
0.020
Why?
Carcinoma
1
2000
191
0.020
Why?
Drug Therapy, Combination
1
1999
382
0.020
Why?
Mice, Inbred BALB C
3
1982
632
0.020
Why?
Mice, Inbred C3H
1
1998
236
0.020
Why?
Regional Blood Flow
1
1998
185
0.020
Why?
Neoplasm, Residual
1
1997
21
0.020
Why?
Base Sequence
1
2001
1683
0.020
Why?
Pilot Projects
2
1985
442
0.020
Why?
Karnofsky Performance Status
1
1996
14
0.020
Why?
Information Systems
1
1996
18
0.020
Why?
Movement
2
1973
164
0.020
Why?
Hematopoietic Cell Growth Factors
1
1995
16
0.020
Why?
Bone Marrow Diseases
1
1995
43
0.020
Why?
Calcium
1
2002
1083
0.020
Why?
Fluorescent Antibody Technique
2
1985
283
0.020
Why?
Dogs
1
1995
468
0.020
Why?
Terminology as Topic
1
1995
109
0.010
Why?
Tumor Necrosis Factor-alpha
1
1998
659
0.010
Why?
Immunoglobulin G
2
1985
488
0.010
Why?
Gallium Radioisotopes
1
1992
8
0.010
Why?
Evaluation Studies as Topic
1
1992
245
0.010
Why?
Neoplasm Invasiveness
1
1992
155
0.010
Why?
Postoperative Period
1
1992
84
0.010
Why?
Biopsy
1
1992
362
0.010
Why?
Spleen
1
1992
341
0.010
Why?
Vinblastine
1
1990
27
0.010
Why?
Dacarbazine
1
1990
21
0.010
Why?
Surgical Procedures, Operative
1
1992
111
0.010
Why?
Heart Function Tests
1
1990
33
0.010
Why?
Drug Administration Schedule
1
1990
366
0.010
Why?
Sensitivity and Specificity
1
1992
905
0.010
Why?
Electrocardiography
1
1993
773
0.010
Why?
Liver
1
1992
877
0.010
Why?
Hybridomas
1
1986
65
0.010
Why?
Antigen-Antibody Complex
1
1986
55
0.010
Why?
Premedication
1
1985
20
0.010
Why?
Carcinoma, Small Cell
1
1985
32
0.010
Why?
Myeloma Proteins
1
1985
11
0.010
Why?
Urinary Tract
1
1985
8
0.010
Why?
Binding Sites, Antibody
1
1985
32
0.010
Why?
Antibody-Dependent Cell Cytotoxicity
1
1985
28
0.010
Why?
Centrifugation
1
1984
46
0.010
Why?
Erythrocyte Count
1
1984
28
0.010
Why?
Skinfold Thickness
2
1973
7
0.010
Why?
London
2
1973
19
0.010
Why?
Complement System Proteins
1
1985
113
0.010
Why?
Leukocyte Count
1
1984
161
0.010
Why?
Elasticity
2
1973
85
0.010
Why?
Immunoenzyme Techniques
1
1985
220
0.010
Why?
Central Nervous System
1
1985
113
0.010
Why?
Bone Marrow Cells
1
1985
221
0.010
Why?
Lung
1
1990
1159
0.010
Why?
Cell Survival
1
1985
551
0.010
Why?
Etanidazole
1
1982
24
0.010
Why?
Chemistry, Pharmaceutical
1
1982
22
0.010
Why?
Injections, Intravenous
1
1982
131
0.010
Why?
Administration, Oral
1
1982
308
0.010
Why?
Cell Line
1
1986
1585
0.010
Why?
Kinetics
1
1982
1391
0.010
Why?
Metacarpus
1
1975
4
0.000
Why?
Elbow
1
1975
15
0.000
Why?
Knee
1
1975
22
0.000
Why?
Ankle
1
1975
22
0.000
Why?
Finger Joint
1
1975
26
0.000
Why?
Wrist
1
1975
50
0.000
Why?

Visualizations


Constine's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department